< Back to previous page
Researcher
Frédéric Amant
- Disciplines:Gynaecology
Affiliations
- Gynaecological Oncology (Division)
Responsible
From1 Mar 2006 → Today - Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
41 - 50 of 61
- iKap: Targeting nucleocytoplasmic transport for novel anti-cancer therapy.From1 Oct 2015 → 30 Nov 2019Funding: SBO (Strategic basic research)
- Postpartum breast cancer diagnosed during the post-weaning period: a distinct entity with unique clinicopathological, molecular and immunological features?From22 Sep 2015 → 9 Jan 2023Funding: Private funding of national origin - undefined
- Combining metabolomics and genomics technologies to study platinum-based therapeutic failure in high grade ovarian cancers: from predictive signature(s) to novel therapeutic strategies.From1 Sep 2015 → 31 Aug 2019Funding: Private funding of national origin - undefined
- Unraveling carboplatin resistance mechanisms in triple negative breast cancerFrom1 Nov 2014 → 26 May 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Nuclear-cytoplasmic transport as novel therapeutic target.From1 Oct 2014 → 30 Sep 2018Funding: IOF - Industrial Research Fund
- Cancer and pregnancy: in depth analysis of an international registry with focus on breast cancer.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Cancer during pregnancy: long-term follow-up of neuropsychological and behavioral development of children after antenatal exposure to chemo- and/or radiotherapyFrom1 Nov 2013 → 3 Mar 2019Funding: FWO fellowships
- Establishment of an in vivo platform of patient-derived xenografts of several tumor types to study tailored cancer treatment.From1 Oct 2013 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
- ‘Cancer in Pregnancy’: Effects of prenatal exposure to cancer treatment on IUGR. To examine the potential biomarkers to develop insights in the underlying pathophysiologic mechanisms of IUGR.From1 Aug 2013 → 2 Feb 2018Funding: Nonprofit institution or equivalents, FWO fellowships
- Preclinical evaluation of targeted therapies in endometrial cancer: use of primary in vitro and in vivo models.From1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 584
- Comprehensive Recommendations for the Clinical Management of Pregnant Women With Noninvasive Prenatal Test Results Suspicious of a Maternal Malignancy.(2024)
Authors: Liesbeth Lenaerts, Frédéric Amant, Miel Theunis, Joris Vermeesch
Pages: OP2300594 - Long-term outcomes of children after prenatal exposure to maternal cancer and its treatment(2024)
Authors: Indra Van Assche, Frédéric Amant
- Results of an international survey on the current organization of care for pregnant women with cancer(2024)
Authors: Joosje Heimovaara, Kristel Van Calsteren, Frédéric Amant
- Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study.(2024)
Authors: Ilana Struys, Lode Godderis, Heidi Segers, Bernard Thienpont, Kristel Van Calsteren, Liesbeth Lenaerts, Frédéric Amant
Pages: e081833 - Sentinel lymph node biopsy for breast cancer during pregnancy: A comprehensive update(2024)
Authors: Frédéric Amant
- ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.(2024)
Authors: Frédéric Amant, Ignace Vergote
Pages: 248 - 266 - Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass.(2024)
Authors: Frédéric Amant
Pages: ijgc-2023- - Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database(2024)
Authors: Joren Vanbraband, Frédéric Amant
Pages: 70 - 78 - Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI(2023)
Authors: Vincent Vandecaveye, Elleke Dresen, Els Van Nieuwenhuysen, Thaïs Baert, Frédéric Amant, Toon Van Gorp
Pages: 1890 - 1897 - Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk(2023)
Authors: Frédéric Amant
Pages: 1931 - 1944